Article
Chromatin remodellers as therapeutic targets.
Nature reviews. Drug discovery - 1 Sept 2024
Malone Hayden A, Roberts Charles W M
Abstract excerpt
Large-scale cancer genome sequencing studies have revealed that chromatin regulators are frequently mutated in cancer. In particular, more than 20% of cancers harbour mutations in genes that encode subunits of SWI/SNF (BAF) chromatin remodelling complexes. Additional links of SWI/SNF complexes to disease have emerged with the findings that some oncogenes drive transformation by co-opting SWI/SNF function and that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
